Clinical trial
A Prospective, Non-randomized, Multicenter Evaluation of the Utility of Transcutaneous Stimulation of the Lumbosacral Nerve Roots During XLIF® and Its Relationship to Postoperative Nerve Health
NCT02272140 is registered in ClinicalTrials.gov with NuVasive as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Non-randomized, Multicenter Evaluation of the Utility of Transcutaneous Stimulation of the Lumbosacral Nerve Roots During XLIF® and Its Relationship to Postoperative Nerve Health
- Lead sponsor
- NuVasive
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 9, 2014
- Completion date
- October 31, 2017
- Enrollment
- 324 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative lumbar disc disease